Proinsulin: Clinical Definition and Use
Proinsulin is the precursor molecule to insulin that is NOT routinely measured in clinical practice for diabetes management, but serves specific diagnostic roles in evaluating hypoglycemia and distinguishing between endogenous and exogenous insulin causes 1.
What is Proinsulin?
Proinsulin is the single-chain precursor protein synthesized by pancreatic β-cells that is cleaved to produce insulin and C-peptide. In healthy individuals, proinsulin comprises only a small fraction of circulating insulin-related peptides, as it is normally processed efficiently within the β-cells before secretion 2, 3.
Clinical Applications
Primary Indication: Hypoglycemia Evaluation
The main clinical utility of proinsulin measurement is in the diagnostic workup of hypoglycemic disorders, particularly when investigating suspected insulinomas or other causes of endogenous hyperinsulinism 4.
Diagnostic criteria during hypoglycemia (plasma glucose <55 mg/dL):
- Proinsulin ≥5.0 pmol/L indicates endogenous hyperinsulinism
- Must be measured alongside insulin (≥3.0 µU/mL) and C-peptide (≥0.6 ng/mL)
- An elevated proinsulin-to-insulin ratio strongly suggests an islet cell tumor 1, 4
When to Measure Proinsulin
During spontaneous or provoked hypoglycemia episodes:
- Obtain simultaneous measurements of glucose, insulin, C-peptide, proinsulin, and β-hydroxybutyrate
- Screen for oral hypoglycemic agents
- Administer 1.0 mg glucagon IV and observe glucose response 4
If spontaneous episodes cannot be captured:
- Conduct a supervised 72-hour fast
- Measure the same panel when glucose drops below 55 mg/dL 4
NOT Recommended for Routine Use
The 2023 Diabetes Care guidelines explicitly state that routine testing for proinsulin in people with diabetes or at risk for diabetes is NOT recommended 1. These assays are primarily useful for research purposes, not clinical management of diabetes.
Key points:
- Do not use proinsulin to diagnose type 1 vs type 2 diabetes (use C-peptide instead if needed)
- Do not use proinsulin to assess insulin resistance in polycystic ovary syndrome
- Do not use proinsulin for routine diabetes monitoring or treatment decisions 1
Important Clinical Caveats
Insulinoma Detection
In patients with documented endogenous hyperinsulinemic hypoglycemia, the absence of elevated proinsulin makes an islet cell tumor highly unlikely, and alternative explanations should be sought 1. The proinsulin criterion (≥5.0 pmol/L) may be met even when insulin levels are borderline, making it a sensitive marker 4.
Post-Bariatric Surgery Hypoglycemia
Elevated proinsulin levels can occur in nesidioblastosis following gastric bypass surgery, typically manifesting in the postprandial period many months after surgery 4.
Measurement Considerations
- Proinsulin levels must be interpreted in the context of simultaneous glucose levels
- Renal insufficiency can affect interpretation
- Modern LC-MS/MS assays can distinguish intact proinsulin from partially processed forms (des-31,32 and des-64,65 proinsulin) 5
Pitfalls to Avoid
Do not order proinsulin for:
- Routine diabetes screening or diagnosis
- Assessing β-cell function in established diabetes (use C-peptide)
- Evaluating insulin resistance
- Differentiating diabetes types in typical presentations 1
Do order proinsulin when:
- Investigating unexplained hypoglycemia in a seemingly well individual
- Suspecting an insulinoma based on clinical presentation
- Evaluating for factitious hypoglycemia (to distinguish endogenous from exogenous insulin) 4